Pa Juni 16-17, 2023, MedGence adatenga nawo gawo pamsonkhano wa High-Quality Development of Healthcare Industry & the 8th Summit for China Pharmaceutical R&D Innovation, womwe udachitika bwino ku Chongqing.
MedGence adalemekezedwa ngati m'modzi mwa "2023 Top 20 R&D CRO Enterprises ku China"!
Choyamba, pamwambo wotsegulira, mindandanda ya "2022 China Pharmaceutical R&D Strength Ranking" idatulutsidwa ndipo MedGence idalemekezedwa ngati imodzi mwa "2023 Top 20 Pharmaceutical CRO Enterprises in China"!
"2023 Pharmaceutical CRO Enterprises in China" idasankhidwa ndi CRO Ranking Expert Review Committee kutengera zizindikiro 10 ndi miyeso ingapo, monga ndalama zonse zapachaka (ndalama zogwirira ntchito), kukula kwa ndalama zapachaka (%), phindu lonse, kukula kwa phindu (%), ndalama za R&D, kukula kwa ndalama za R&D (%), kukula kwa ogwira ntchito, kukula kwa ogwira ntchito (mavoti a utsogoleri), mtundu wa utsogoleri, ndi zina. kampani yotsogola ya TCM yatsopano yopanga mankhwala, yomwe idapambana mphoto ya "2023 Top 20 Pharmaceutical CRO Enterprises in China", idawonetsa kuthekera ndi mphamvu zake.
Panthawiyi, monga mtsogoleri wa TCM CXO, Dr. Yi Yueneng, Wapampando & General Manager wa MedGence, adaitanidwa kuti apite ku Msonkhano Wachisanu ndi chitatu wa China Pharmaceutical R & D Innovation ndipo anakamba nkhani pa "Kuyambira Pamapeto - Njira Zopangira Zatsopano Zamankhwala Achi China". Ananenanso kuti pakali pano, mapangidwe apamwamba kwambiri a chitukuko cha mankhwala aku China afulumizitsidwa ndikuwongoleredwa, malo oyendetsera ndondomeko akhala akukonzedwa mosalekeza ndipo chithandizo chawonjezeka, ndipo mankhwala aku China abweretsa zaka zabwino kwambiri. Iye anakonza ndondomeko chilengedwe, kafukufuku ndi chitukuko ndondomeko, ndi mmene ntchito chitukuko cha chikhalidwe Chinese mankhwala makampani mu nyengo yatsopano, anasonyeza ubale zomveka mkati, kusanthula mavuto amene akadalipo pa chitukuko cha zamakono makampani Chinese mankhwala, ndipo akufuna countermeasures zotheka.
Kenaka, Dr. Yi Yueneng, monga woyang'anira msonkhano wozungulira "Is the Spring of Chinese Medicine New Product R & D Coming", adakambirana pamodzi zochitika ndi zovuta za R & D ndi zatsopano za mankhwala achi China ndi osewera makampani. Monga wotsogolera wamkulu, MedGence wakhala akukhazikika m'makampani opanga mankhwala, kufufuza mwakhama, kumapanga zatsopano, kulimbikitsa chitukuko cha mafakitale, ndikupitirizabe kutumikira makampani opanga mankhwala kuzungulira China.
Msonkhanowo udakopa atsogoleri ambiri pankhani yazamankhwala, makoleji ndi mayunivesite, mabungwe ofufuza, makampani opanga mankhwala, mayunitsi a R & D ndi osankhika ena ambiri kuti achite nawo malipoti amtundu wa R & D wamankhwala achi China, kukonza luso, malamulo ndi mfundo, khalidwe ndi chitetezo, kukhathamiritsa, zida zatsopano, matekinoloje atsopano, ndi zina zambiri. Mankhwala, monga mmodzi mwa owonetsa apadera a chochitikacho, ali ndi nyumba yapadera, yomwe inakopa antchito ambiri ogwira nawo ntchito kuti ayendere! Pamsonkhanowu, monga m'modzi mwa owonetsa omwe adaitanidwa, Enable Pharma anali ndi nyumba yapadera, yomwe idakopa ogwira nawo ntchito ambiri kuti akachezere malowa kuti akakambirane, kulumikizana kwambiri ndi makampani akuluakulu opanga mankhwala, komanso kufunikira kwa docking kwa kafukufuku wamankhwala ndi chitukuko.
Nthawi yotumiza: Jul-15-2023